Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis (Q35746384)
scientific article published on March 2001
Language:
(P31) (Q13442814)
(P304) 987-996
(P407) (Q1860)
(P433) 3
(P478) 158
(P577) Thursday, March 1, 2001
(P1433) (Q4744259)
(P1476) "Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis" (language: en)
(P2093) Garcia-Rostan G
Camp RL
Herrero A
Carcangiu ML
Rimm DL
Tallini G
(P2860) (Q29620188)
(Q35745470)
(Q33814311)
(Q41896173)
(Q35787861)
(Q40930487)
(Q41936644)
(Q34461429)
(Q52552917)
(Q29620190)
(Q24336321)
(Q36237334)
(Q36237152)
(Q36080630)
(Q35596740)
(Q42775572)
(Q54089799)
(Q57413414)
(Q77803739)
(Q77407092)
(Q73266828)
(Q77873140)
(Q70607589)
(Q69038262)
(Q78100038)
(Q78015051)
(Q70564412)
(Q77977516)
(Q74092214)
(Q77304024)
(Q77357530)
(Q78056486)
(Q70487660)
other details
description scientific article published on March 2001

External Links